Case number 1:17-cv-01634
ViiV Healthcare Company et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 16, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per [27] Consent Judgment. (kmd) |
| Aug 3, 2021 | 28 | Patent/Trademark Report to Commissioner (1) Docket Text: Final Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (smg) |
| Aug 3, 2021 | 27 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT. Signed by Judge Mitchell S. Goldberg on 8/3/2021. Associated Cases: 1:17-cv-01576-MSG-RL, 1:17-cv-01634-MSG(kmd) |
| Jul 30, 2021 | 26 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) |
| Aug 15, 2018 | 25 | Letter (1) Docket Text: Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw) |
| Jun 20, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (59 in 1:17-cv-01576-MSG-RL) STIPULATION TO EXTEND TIME the Deadline for the Parties to Jointly Submit a Proposed Protective Order to Friday, June 22, 2018 filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. The deadline for the parties to jointly submit a proposed protective order is extended to Friday, June 22, 2018. Signed by Judge Richard A. Lloret on 6/20/2018. Associated Cases: 1:17-cv-01576-MSG-RL et al.(RL) |
| Apr 6, 2018 | 23 | Order (3) Docket Text: ORDER of Consolidation. All filings shall be made in lead case Civil Action No. 17-1576. Signed by Judge Mitchell S. Goldberg on 4/6/2018. Associated Cases: 1:17-cv-01576-MSG et al.(fms) |
| Apr 6, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-01576-MSG. (fms) |
| Apr 5, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Rule 16 teleconference held on 4/5/2018. Associated Cases: 1:17-cv-01576-MSG et al.(fms) |
| Apr 3, 2018 | 22 | Letter (2) Docket Text: Letter to The Honorable Mitchell S. Goldberg from James M. Lennon regarding Request for Rule 16 Conference be Held Telephonically. (Lennon, James) |
| Apr 2, 2018 | 21 | Order Setting Scheduling Conference (4) Docket Text: Order RESCHEDULING Rule 16 Conference to Thursday, April 5, 2018 at 12:00 PM before Judge Mitchell S. Goldberg at the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, PA, 19106, in Courtroom 6-A. Signed by Judge Mitchell S. Goldberg on 4/2/2018. Associated Cases: 1:17-cv-01576-MSG et al.(ceg) |
| Mar 30, 2018 | 20 | Text of Proposed Order Proposed Scheduling Order [Reflecting Agreed Upon and Dis (14) |
| Mar 30, 2018 | 20 | Main Document (20) Docket Text: REDACTED VERSION of (22 in 1:17-cv-01784-MSG) Proposed Discovery Plan, by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Text of Proposed Order Proposed Scheduling Order [Reflecting Agreed Upon and Disputed Provisions])(Silver, Daniel) |
| Mar 29, 2018 | 18 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited.(Silver, Daniel) |
| Mar 29, 2018 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex, Inc. and Apotex, Corp.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1) filed by Apotex Corp., Apotex Inc..(Vrana, Robert) |
| Feb 28, 2018 | 16 | Order Setting Scheduling Conference (4) Docket Text: ORDER that, upon consideration of a Stipulation filed on 2/14/18, in each of the above-captioned cases except for 17-1671, it is ORDERED: 1) The Oral Order of Magistrate Judge Christopher J. Burke, referenced in the Stipulation, is - in each of the above cases in which it was entered - VACATED. Accordingly, the Stipulation is DENIED AS MOOT. 2) A Rule 16 Conference is set for 4/5/2018 at 10:00 AM in the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, PA, in Courtroom 4B before Judge Mitchell S. Goldberg. 3) Counsel shall consult Judge Goldberg's Polices and Procedures prior to the conference, etc. 4) Counsel shall be prepared to discuss consolidation of the above-captioned cases during the Rule 16 Conference. Signed by Judge Mitchell S. Goldberg on 2/28/18. Associated Cases: 1:17-cv-01576-MSG et al.(gvw) |
| Feb 14, 2018 | 15 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME See Stipulation for Details to Friday, March 9, 2018 (from Friday, February 16, 2018) - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) |
| Feb 13, 2018 | 14 | Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Filko Prugo as co-counsel.. (Silver, Daniel) |
| Feb 7, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carolyn Wall for ViiV Healthcare Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01576-MSG et al.(ceg) |
| Jan 18, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:17-cv-01576-MSG, 1:17-cv-01634-MSG, 1:17-cv-01670-MSG, 1:17-cv-01671-MSG, 1:17-cv-01678-MSG, 1:17-cv-01737-MSG, 1:17-cv-01741-MSG and 1:17-cv-01784-MSG (rjb) |
| Jan 5, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel O'Boyle for ViiV Healthcare Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Jan 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Caitlin Hogan for ViiV Healthcare Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01576-VAC-CJB et al.(ceg) |
| Dec 28, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (8 in 1:17-cv-01784-VAC-CJB, 11 in 1:17-cv-01634-VAC-CJB, 9 in 1:17-cv-01671-VAC-CJB, 11 in 1:17-cv-01737-VAC-CJB, 11 in 1:17-cv-01678-VAC-CJB) MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. Ordered by Judge Christopher J. Burke on 12/28/2017. Associated Cases: 1:17-cv-01576-VAC-CJB et al.(dlb) |
| Dec 19, 2017 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME See Stipulation for Details to February 16, 2018 - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) |
| Dec 19, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [13] STIPULATION TO EXTEND TIME See Stipulation for Details to February 16, 2018 filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. Ordered by Judge Christopher J. Burke on 12/19/2017. (dlb) |
| Dec 14, 2017 | 12 | Notice (Other) (4) Docket Text: NOTICE of Appearance (Lisa B. Pensabene) by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited (Silver, Daniel) |
| Dec 14, 2017 | 11 | Certifications for Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan (4) |
| Dec 14, 2017 | 11 | Main Document (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Certifications for Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan)Motions referred to Christopher J. Burke.(Silver, Daniel) |
| Dec 4, 2017 | 10 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Poff, Adam) |
| Dec 4, 2017 | 9 | Answer to Complaint (15) Docket Text: ANSWER to [1] Complaint, by Apotex Corp., Apotex Inc..(Poff, Adam) |
| Dec 4, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burkes Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (I) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order consistent with Judge Burkes Rule 16 Scheduling Order Patent; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule an in-person Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Rule 16 Scheduling Order Patent can be found on this Court's website (http://www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke). Ordered by Judge Christopher J. Burke on 12/4/2017. (dlb) |
| Nov 15, 2017 | N/A | Remark (0) Docket Text: REMARK: If the parties jointly consent to have a Magistrate Judge conduct all proceedings in this case, including trial, then when Judge Burke enters a case schedule he will enter the respective pre-trial conference and trial dates onto his calendar and will honor them. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued on May 26, 2017 and available on the District Court's website), then upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be considered ready for reassignment to a visiting District Judge. Whether the pre-trial conference and trial dates will stand after reassignment will depend on the availability of those dates on the visiting District Judge's calendar. (dlb) |
| Nov 15, 2017 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf (dlb) |
| Nov 15, 2017 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb) |
| Nov 15, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| Nov 14, 2017 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. Apotex Corp. served on 11/13/2017, answer due 12/4/2017. (Silver, Daniel) |
| Nov 14, 2017 | 7 | Exhibit A & B (6) |
| Nov 14, 2017 | 7 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Apotex Inc. made on November 13, 2017 by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Exhibit A & B)(Silver, Daniel) |
| Nov 13, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 11/13/2017; Apotex Inc. on 11/13/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Nov 10, 2017 | 1 | Main Document (12) Docket Text: COMPLAINT filed FOR PATENT INFRINGEMENT against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2264337.) - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs) |
| Nov 10, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited, Corporate Parent Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (jcs) |
| Nov 10, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (jcs) |
| Nov 10, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (jcs) |
| Nov 10, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: December 8, 2029.Thirty Month Stay Deadline: 02/12/2021. (jcs) |
| Nov 10, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Nov 10, 2017 | 1 | Civil Cover Sheet (1) |
| Nov 10, 2017 | 1 | Exhibit A (32) |
| Nov 10, 2017 | 1 | Complaint* (1) |
